These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8729757)

  • 1. Autoantibodies before, during and after administration of recombinant interferon-alpha for chronic viral hepatitis.
    Lopes EP; Silva AE; Sette Junior H; Guimarães RX; Ferraz ML
    Rev Inst Med Trop Sao Paulo; 1995; 37(5):455-60. PubMed ID: 8729757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis.
    di Cesare E; Previti M; Russo F; Brancatelli S; Ingemi MC; Scoglio R; Mazzù N; Cucinotta D; Raimondo G
    Dig Dis Sci; 1996 Aug; 41(8):1672-7. PubMed ID: 8769300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies during alpha-interferon therapy for chronic hepatitis B.
    Fattovich G; Betterle C; Brollo L; Pedini B; Giustina G; Realdi G; Alberti A; Ruol A
    J Med Virol; 1991 Jun; 34(2):132-5. PubMed ID: 1890413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.
    Rostaing L; Oksman F; Izopet J; Baron E; Cisterne JM; Hoff M; Abbal M; Durand D
    Am J Nephrol; 1996; 16(6):478-83. PubMed ID: 8955758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
    Chung YH; Shong YK
    Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis.
    Mayet WJ; Hess G; Gerken G; Rossol S; Voth R; Manns M; Meyer zum Büschenfelde KH
    Hepatology; 1989 Jul; 10(1):24-8. PubMed ID: 2737600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis.
    Imagawa A; Itoh N; Hanafusa T; Oda Y; Waguri M; Miyagawa J; Kono N; Kuwajima M; Matsuzawa Y
    J Clin Endocrinol Metab; 1995 Mar; 80(3):922-6. PubMed ID: 7883851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of r-interferon alpha administration on hypothalamus-pituitary-thyroid axis in chronic hepatitis.
    Falaschi P; D'Urso R; Proietti A; Martocchia A; Pastore R; Angelucci L
    Life Sci; 1997; 60(1):43-50. PubMed ID: 8995531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet antibodies in patients with chronic viral hepatitis receiving interferon-alpha.
    Christodoulou D; Christou L; Zervou E; Katsanos K; Kitsanou M; Tsianos EV
    Hepatogastroenterology; 2007 Sep; 54(78):1761-5. PubMed ID: 18019713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis.
    Saracco G; Touscoz A; Durazzo M; Rosina F; Donegani E; Chiandussi L; Gallo V; Petrino R; De Micheli AG; Solinas A
    J Hepatol; 1990 Nov; 11(3):339-43. PubMed ID: 2127054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatitis: our studies and review of the literature.
    Nagayama Y; Ohta K; Tsuruta M; Takeshita A; Kimura H; Hamasaki K; Ashizawa K; Nakata K; Yokoyama N; Nagataki S
    Endocr J; 1994 Oct; 41(5):565-72. PubMed ID: 7889118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic hepatitis B and C with alpha interferon].
    Hess G
    Z Gastroenterol Verh; 1991 Mar; 26():149-51. PubMed ID: 1714130
    [No Abstract]   [Full Text] [Related]  

  • 14. The interferon-alpha 2b gene in Japanese patients with chronic viral hepatitis who developed antibodies after treatment with recombinant interferon-alpha 2a.
    Hosoi H; Imai M; Yamanaka M
    J Gastroenterol Hepatol; 1992; 7(4):411-6. PubMed ID: 1515568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the presence of serum autoantibodies influence the responsiveness to interferon-alpha 2a treatment in chronic hepatitis C?
    Wada M; Kang KB; Kinugasa A; Shintani S; Sawada K; Nishigami T; Shimoyama T
    Intern Med; 1997 Apr; 36(4):248-54. PubMed ID: 9187562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C.
    Baudin E; Marcellin P; Pouteau M; Colas-Linhart N; Le Floch JP; Lemmonier C; Benhamou JP; Bok B
    Clin Endocrinol (Oxf); 1993 Dec; 39(6):657-61. PubMed ID: 8287583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term therapy with recombinant interferon alpha 2 b in patients with chronic hepatitis C: effects on thyroid function and autoantibodies.
    Barreca T; Picciotto A; Franceschini R; Varagona G; Corsini G; Valle F; Cataldi A; Molinari E; Garibaldi A; Rolandi E
    J Biol Regul Homeost Agents; 1993; 7(2):58-62. PubMed ID: 8266816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study.
    Mazziotti G; Sorvillo F; Stornaiuolo G; Rotondi M; Morisco F; Ruberto M; Cioffi M; Amato G; Caporaso N; Gaeta GB; Carella C
    J Endocrinol Invest; 2002; 25(7):624-30. PubMed ID: 12150338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
    Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
    Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid autoantibodies and thyroid dysfunction during treatment with interferon-alpha for chronic hepatitis C.
    Kiehne K; Kloehn S; Hinrichsen H; Gallwitz B; Mönig H
    Endocrine; 1997 Jun; 6(3):231-4. PubMed ID: 9368677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.